Skip to main content
AAPL-0.46%MSFT+0.82%NVDA+4.55%GOOGL-1.24%AMZN+0.96%SPCX+3.16%TSM-3.68%AVGO+2.46%META+0.61%TSLA+1.11%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.63%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.16%0700.HK-0.08%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.05%UNH-5.42%ORCL-3.38%3988.HK-0.35%BAC-1.28%HD-2.45%GE+0.38%0857.HK+0.97%1816.HK-27.19%1288.HK-0.33%0005.HK-1.40%PM-0.85%NVS-0.67%HSBA.L-1.95%INTC-0.54%MS-1.10%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.67%AUDUSD-0.60%GBPAUD+0.54%NZDJPY-0.53%NZDUSD-0.43%GBPTRY+0.41%GBPNZD+0.40%AUDCHF-0.39%EURJPY-0.37%CADJPY-0.35%AUDCAD-0.33%EURAUD+0.32%GBPHKD+0.32%CHFJPY-0.28%GBPMXN-0.28%EURUSD-0.27%USDCAD+0.26%NZDCHF-0.23%USDCHF+0.23%EURGBP-0.23%GBPCAD+0.22%NZDMXN+0.21%GBPCHF+0.19%NZDCAD-0.19%EURNZD+0.16%USDTRY+0.16%USDILS+0.16%USDTHB-0.16%AUDNZD-0.16%NZDSGD+0.14%GBPJPY-0.13%USDPLN+0.13%USDCNH-0.11%SGDJPY+0.10%USDJPY-0.10%USDMXN+0.09%USDZAR+0.09%NOKJPY+0.08%EURPLN+0.07%USDDKK+0.07%EURHKD-0.06%GBPZAR+0.06%USDSEK+0.06%EURCNH-0.05%EURSGD-0.05%CADCHF-0.04%CHFSEK+0.04%USDCOP-0.04%EURCHF-0.04%GBPUSD-0.03%USDNOK+0.03%EURNOK-0.03%AUDSGD-0.03%AUDDKK+0.03%CHFNOK+0.01%EURZAR+0.01%USDSGD+0.01%PLNJPY-0.01%USDHKD+0.01%AUDNOK-0.01%EURSEK-0.01%EURDKK0.00%EURCAD0.00%CHFSGD0.00%GBPSGD0.00%EURCZK0.00%GAGUSD-1.00%XAGUSD-0.99%GAUUSD-0.81%XAUUSD-0.81%W1-0.39%UKOIL-0.31%XPTUSD-0.27%USOIL-0.25%HG1+0.23%S1+0.22%C1-0.09%XNGUSD+0.07%BTCUSD-0.61%ETHUSD+58.05%USDTUSD-0.03%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+1.09%ZECUSDT+5.50%XMRUSDT+2.72%DOGEUSD+59.04%LINKUSD+0.66%XLMUSD+1.74%BCHUSDT+0.58%LTCUSD+50.36%UNIUSD+1.28%TONUSD+63.46%SUIUSD+1.35%HBARUSDT+0.15%TAOUSDT+2.26%AAVEUSD+2.74%ONDOUSDT-0.03%ICPUSDT-7.74%DOTUSDT+0.09%WLDUSDT+1.09%ARBUSDT-0.05%INJUSDT+6.09%ATOMUSDT-0.92%STXUSDT+5.13%PYTHUSDT+0.78%TIAUSDT-0.78%FETUSDT-0.49%SEIUSDT+1.04%JUPUSDT+7.77%GRTUSDT+4.02%OPUSDT-2.36%IOTAUSDT+2.37%POLUSDT+3.10%WIFUSDT-0.31%AXSUSDT+0.53%EOSUSDT+1.92%FARTCOINUSDT-2.89%IMXUSDT+0.96%GALAUSDT-1.96%DYDXUSDT+1.69%ORDIUSDT-0.49%NOTUSDT-1.46%RONINUSDT+2.00%AAPL-0.46%MSFT+0.82%NVDA+4.55%GOOGL-1.24%AMZN+0.96%SPCX+3.16%TSM-3.68%AVGO+2.46%META+0.61%TSLA+1.11%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.63%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.16%0700.HK-0.08%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.05%UNH-5.42%ORCL-3.38%3988.HK-0.35%BAC-1.28%HD-2.45%GE+0.38%0857.HK+0.97%1816.HK-27.19%1288.HK-0.33%0005.HK-1.40%PM-0.85%NVS-0.67%HSBA.L-1.95%INTC-0.54%MS-1.10%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.67%AUDUSD-0.60%GBPAUD+0.54%NZDJPY-0.53%NZDUSD-0.43%GBPTRY+0.41%GBPNZD+0.40%AUDCHF-0.39%EURJPY-0.37%CADJPY-0.35%AUDCAD-0.33%EURAUD+0.32%GBPHKD+0.32%CHFJPY-0.28%GBPMXN-0.28%EURUSD-0.27%USDCAD+0.26%NZDCHF-0.23%USDCHF+0.23%EURGBP-0.23%GBPCAD+0.22%NZDMXN+0.21%GBPCHF+0.19%NZDCAD-0.19%EURNZD+0.16%USDTRY+0.16%USDILS+0.16%USDTHB-0.16%AUDNZD-0.16%NZDSGD+0.14%GBPJPY-0.13%USDPLN+0.13%USDCNH-0.11%SGDJPY+0.10%USDJPY-0.10%USDMXN+0.09%USDZAR+0.09%NOKJPY+0.08%EURPLN+0.07%USDDKK+0.07%EURHKD-0.06%GBPZAR+0.06%USDSEK+0.06%EURCNH-0.05%EURSGD-0.05%CADCHF-0.04%CHFSEK+0.04%USDCOP-0.04%EURCHF-0.04%GBPUSD-0.03%USDNOK+0.03%EURNOK-0.03%AUDSGD-0.03%AUDDKK+0.03%CHFNOK+0.01%EURZAR+0.01%USDSGD+0.01%PLNJPY-0.01%USDHKD+0.01%AUDNOK-0.01%EURSEK-0.01%EURDKK0.00%EURCAD0.00%CHFSGD0.00%GBPSGD0.00%EURCZK0.00%GAGUSD-1.00%XAGUSD-0.99%GAUUSD-0.81%XAUUSD-0.81%W1-0.39%UKOIL-0.31%XPTUSD-0.27%USOIL-0.25%HG1+0.23%S1+0.22%C1-0.09%XNGUSD+0.07%BTCUSD-0.61%ETHUSD+58.05%USDTUSD-0.03%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+1.09%ZECUSDT+5.50%XMRUSDT+2.72%DOGEUSD+59.04%LINKUSD+0.66%XLMUSD+1.74%BCHUSDT+0.58%LTCUSD+50.36%UNIUSD+1.28%TONUSD+63.46%SUIUSD+1.35%HBARUSDT+0.15%TAOUSDT+2.26%AAVEUSD+2.74%ONDOUSDT-0.03%ICPUSDT-7.74%DOTUSDT+0.09%WLDUSDT+1.09%ARBUSDT-0.05%INJUSDT+6.09%ATOMUSDT-0.92%STXUSDT+5.13%PYTHUSDT+0.78%TIAUSDT-0.78%FETUSDT-0.49%SEIUSDT+1.04%JUPUSDT+7.77%GRTUSDT+4.02%OPUSDT-2.36%IOTAUSDT+2.37%POLUSDT+3.10%WIFUSDT-0.31%AXSUSDT+0.53%EOSUSDT+1.92%FARTCOINUSDT-2.89%IMXUSDT+0.96%GALAUSDT-1.96%DYDXUSDT+1.69%ORDIUSDT-0.49%NOTUSDT-1.46%RONINUSDT+2.00%
ST

Stryker Corporation (SYK)

NYSE • Healthcare

$317.54
+$6.81 (+2.2%)
Market closed

November 17, 2026 at 21:00 UTC

Open$309.12
Day Range$308 - $319.33
Avg. Volume (3M)3.2M
Market Cap$120.8B
P/E Ratio33.6
52 Week Range
$267$389.33
Next EarningsIn 78 daysFeb 4, 2027

Interactive Chart

01:46:59 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$6.5B100%
Gross Profitminus cost of goods$4.2B65%
Operating Incomeminus R&D and overhead$1B16%
Net Incomeminus taxes and the rest$753M12%

In plain terms: out of every $100 in revenue, Stryker Corporation keeps $12 as net profit.

Fundamentals & Financials

Revenue (TTM)
$26.3B
Net Income (TTM)
$3.6B
EPS (TTM)
$9.45
ROA (TTM)
7.67%
Current Ratio
2.18
Dividend Yield
0.32%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-12.8%Q2 2026$2.6
+5.7%Q3 2026$3.69
-0.8%Q4 2026$3.52
Next

Feb 4

in 78 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Miss -0.8%

Stryker’s preliminary third fiscal quarter of 2026 results, reported October 29, 2026, came in with revenue that trailed consensus while adjusted EPS was in line. Revenue rose 7.6% to about $6.5 billion, but still trailed expectations at $6.520 billion versus the $6.617 billion estimate (-1.5%), with the business spanning medical devices across orthopaedic, surgical, neurotechnology, and emergency-care settings. Adjusted EPS of $3.52 came in line with the $3.55 estimate (-0.8%) and was up from $3.19 a year ago (+10.3%), even as net income fell 12.3% year over year to roughly $753 million (down from $859.0 million). Profitability metrics showed a gross margin of 65.2% and an operating margin of 15.9%, with gross profit of about $4.2 billion and operating income of roughly $1.0 billion. For the next period, consensus calls for EPS of $5.07 on revenue of $7.948 billion.

View full earnings history

About Stryker Corporation

Stryker Corporation (NYSE: SYK) makes medical devices for orthopaedic, surgical, neurotechnology, and emergency-care settings. In healthcare, it sells implants for joint replacement procedures, trauma and extremity products, spinal systems, and hospital equipment, and it recorded $25.1 billion of revenue in FY2025.

Name
Stryker Corporation
CEO
Kevin A. Lobo
Industry
Healthcare
Year Founded
1941
Employees
56,000

Today's Snapshot

AI-generated

SYK closed 2.2% higher at 317.60, outperforming a weaker sector.

Trading Volume

Above 10d avg 3.5M

3.6M

vs S&P 500 Today

Strong Outperformance

+3.56%

Updated: November 17, 2026 at 21:11 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
SYK is rated a buy as recent momentum indicators show modest upside while price sits above most short- to mid-term averages. Short-term EMAs and the 20/50-day averages are supportive even though the 10-day simple average and the 200-day remain slightly higher, and MACD and RSI read neutral-to-holding, implying limited follow-through. ADX signals only a weak trend, ATR points to moderate volatility, and on-balance volume looks soft, which tempers conviction. Technical takeaway: Buy — momentum and mid-term moving averages support a modest bullish bias despite weak trend strength and light volume.
All signals
  • EMA (5 indicators)$305.50 - $321.19
    Buy
  • RSI (14)55.56
    Neutral
  • Stochastic %K (14, 3, 3)45.25
    Neutral
  • MACD Level (12, 26)5.91
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.